Cephalon pays Acusphere $10m for HDDS license
Cephalon has licensed the hydrophobic drug delivery system (HDDS) and a reformulated version of paclitaxel, called AI-850, from Acusphere in a $10m deal.
Archives for April 9, 2008
Lung cancer warning a death knell for inhaled insulin?
Pfizer has updated the US product labeling of its inhaled insulin treatment Exubera to include a warning of increased risk of lung cancer among those using it.
PPD, INC Research, Parexel, Cato Research, Pacific Biomarkers and Discovery Laboratories - People on the move
PPD, INC Research, Parexel, Cato Research, Pacific Biomarkers and Discovery Laboratories have all had people on the move in the world of pharmaceutical outsourcing.
BioFocus DPI launches new drug discovery platform
BioFocus DPI, a subsidiary of Galapagos, has launched a new platform for drug discovery at the Society for Biomolecular Sciences Annual Conference taking place this week in St Louis.
Actavis buys Chinese API manufacturer
Actavis has purchased a 90 per cent stake in Zhejiang Chiral Medicine Chemicals (CMC), a Hangzhou, China-based active pharmaceutical ingredients (API) maker.